Arca Biopharma sell StockNews.com
Start price
15.07.23
/
50%
€1.78
Target price
15.07.24
-
Performance (%)
75.28%
End price
16.07.24
€3.12
Summary
This prediction ended on 16.07.24 with a price of €3.12. The SELL prediction by StockNews_com for Arca Biopharma was trending in the completely wrong direction and closed with a performance of 75.28%. StockNews_com has a follow-up prediction for Arca Biopharma where he still thinks Arca Biopharma is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arca Biopharma | -9.494% | -9.494% | 53.351% |
iShares Core DAX® | -0.598% | 0.645% | 10.813% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten